-
Kitsap Respiratory Illness Report: Week 12 (3/16/2025-3/22/2025)
In week ending March 22, local indicators for influenza continued to decrease but remained high, while local indicators for RSV remained elevated, and indicators for COVID-19 remained low. Other Puget Sound counties observed similar trends. Regional laboratory surveillance most frequently detected influenza A and rhinovirus among clinical respiratory specimens. 1.3% of emergency department (ED) visits were attributable to influenza, and…
-
Kitsap Respiratory Illness Report: March 31-April 6
Advisory or Update, Communicable Disease and Immunization Update, Communicable Disease Data Report, COVID-19, Health Advisory, Health Alert, Infection Control, Influenza, Influenza Update, News and Alerts, News and Update, Provider Resources, Respiratory Illness Report, Respiratory Illness ReportClick here to access week 14 of the Kitsap Respiratory Illness Report. In the week ending April 6, local indicators for influenza continued to approach baseline levels. Indicators for COVID-19 and respiratory syncytial virus (RSV) remained low. Fewer than 10 emergency department (ED) visits were attributable to any one of the three monitored respiratory viruses (COVID-19,…
-
Kitsap Respiratory Illness Report: March 24-30
Advisory or Update, Communicable Disease and Immunization Update, Communicable Disease Data Report, COVID-19, Health Advisory, Health Alert, Infection Control, Influenza, Influenza Update, News and Alerts, News and Update, Provider Resources, Respiratory Illness Report, Respiratory Illness ReportClick here to access week 13 of the Kitsap Respiratory Illness Report. In week ending on March 30, local indicators for influenza continued to approach baseline levels. Indicators for COVID-19 and respiratory syncytial virus (RSV) remained low. 0.7% of emergency department (ED) visits were attributable to COVID-19, 0.7% were attributable to influenza, and fewer than 10…
-
Kitsap Respiratory Illness Report: March 17-23
Advisory or Update, Communicable Disease and Immunization Update, Communicable Disease Data Report, COVID-19, Health Advisory, Infection Control, Influenza, Influenza Update, News and Alerts, News and Update, Prevention, Provider Resources, Respiratory Illness Report, Respiratory Illness ReportClick here to access week 12 of the Kitsap Respiratory Illness Report. In week ending on March 23, local indicators for influenza remained elevated. Indicators for COVID-19 and respiratory syncytial virus (RSV) remained low. 0.7% of emergency department (ED) visits were attributable to influenza, and fewer than 10 visits were attributable to COVID-19 and to RSV.…
-
03/27/2024 Health Advisory: Measles Increasing in Washington, the Nation, and the World
Summary Background Measles is a highly contagious viral illness that can lead to severe health complications, like pneumonia, encephalitis, and death, especially in unvaccinated people. Measles outbreaks have occurred in Washington, the United States, and around the world in 2024. Outbreaks often start when an unvaccinated or under-vaccinated person is exposed during international travel and…
-
Kitsap Respiratory Illness Report: March 10-16
Communicable Disease and Immunization Update, Communicable Disease Data Report, COVID-19, Infection Control, Influenza, Influenza Update, Provider Resources, Respiratory Illness Report, Respiratory Illness ReportIn the week ending March 16, local indicators for influenza rebounded slightly, approaching elevated levels observed at the end of December. Indicators for COVID-19 and respiratory syncytial virus (RSV) remained low. 1.1% of emergency department (ED) visits were attributable to COVID-19, 1.2% were attributable to influenza, and fewer than 10 visits were attributable to RSV.…
-
Kitsap Respiratory Illness Report: March 3-9
Advisory or Update, Communicable Disease and Immunization Update, Communicable Disease Data Report, COVID-19, Health Advisory, Health Alert, Infection Control, Influenza, Influenza Update, News and Alerts, News and Update, Respiratory Illness Report, Respiratory Illness ReportClick here to access week 10 of the Kitsap Respiratory Illness Report. In week ending March 9, local indicators for influenza were elevated but approaching baseline levels. Indicators for COVID-19 and respiratory syncytial virus (RSV) were low. 1.2% of emergency department (ED) visits were attributable to COVID-19, 0.7% were attributable to influenza, and fewer than 10…
-
Kitsap Respiratory Illness Report: Feb. 25-March 2
Advisory or Update, Communicable Disease and Immunization Update, Communicable Disease Data Report, Health Advisory, Health Alert, Infection Control, Influenza, Influenza Update, News and Alerts, News and Update, Prevention, Provider Resources, Respiratory Illness Report, Respiratory Illness ReportClick here to access week 9 of the Kitsap Respiratory Illness Report. In the week ending March 2, local indicators for influenza continued to decrease but remained elevated. Indicators for COVID-19 and respiratory syncytial virus (RSV) remained elevated. 1.5% of emergency department (ED) visits were attributable to COVID-19, 0.7% were attributable to influenza, and fewer than…
-
Kitsap Respiratory Illness Report: Feb. 18 to Feb. 24
Advisory or Update, Communicable Disease and Immunization Update, Communicable Disease Data Report, COVID-19, Health Advisory, Health Alert, Infection Control, Influenza, Influenza Update, News and Alerts, News and Update, Provider Resources, Respiratory Illness Report, Respiratory Illness ReportClick here to access week 8 of the Kitsap Respiratory Illness Report. In week ending Feb. 24, local indicators for influenza decreased but remained elevated. Indicators for COVID-19 and respiratory syncytial virus (RSV) continued to decrease. 1.2% of emergency department (ED) visits were attributable to COVID-19, 0.9% were attributable to influenza, and fewer than 10 visits…
-
Health Advisory: Update on measles activity
Advisory or Update, Communicable Disease and Immunization Update, Health Advisory, Health Alert, Infection Control, Measles, News and Alerts, News and Update, Prevention, Provider ResourcesBE AWARE several states, including Washington, have recently experienced local measles activity. Since the beginning of 2024 there have been nine measles cases reported in Washington state, including a cluster of eight cases in Clark and Wahkiakum Counties in January and a travel-associated case with multiple public exposures reported on February 21 in Spokane County. Nationwide, 36 measles cases…
-
Kitsap Respiratory Illness Report: Feb. 11 to Feb. 17
Advisory or Update, Communicable Disease and Immunization Update, Communicable Disease Data Report, Health Advisory, Health Alert, Infection Control, Influenza, Influenza Update, News and Alerts, News and Update, Provider Resources, Respiratory Illness Report, Respiratory Illness ReportClick here to access week 7 of the Kitsap Respiratory Illness Report. In week the week ending on Feb. 17, local indicators for influenza remained elevated. Indicators for COVID-19 and respiratory syncytial virus (RSV) continued to decline but remained slightly above what we’d expect to see outside of respiratory season. 1.4% of emergency department (ED) visits…
-
Kitsap Respiratory Illness Report: Feb. 4 to Feb. 10
Advisory or Update, Communicable Disease and Immunization Update, Communicable Disease Data Report, COVID-19, Health Advisory, Health Alert, Infection Control, Influenza, Influenza Update, News and Alerts, News and Update, Prevention, Provider Resources, Respiratory Illness Report, Respiratory Illness ReportClick here to access week 6 of the Kitsap Respiratory Illness Report. In week ending Feb. 10, local indicators for COVID-19, influenza and RSV remained elevated. Influenza indicators rebounded following decreases the previous week. 2.4% of emergency department (ED) visits were attributable to COVID-19, 0.7% were attributable to influenza, and fewer than 10 visits were attributable…
-
Health Advisory: RSV prevention updates
Summary Background On Oct. 23, 2023, Centers for Disease Control and Prevention (CDC) issued a health alert about the limited supply of nirsevimab. CDC recommended healthcare providers prioritize nirsevimab for infants born later in RSV (respiratory syncytial virus) season or for those at increased risk for severe illness. On Jan. 5, 2024, CDC issued updated guidance about the increased…